Daily Bulletin

Men's Weekly

.

Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

BAGSVÆRD, Denmark, Nov. 6, 2020 /PRNewswire/ -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP 3 phase 3a trial investigated the...

Read more: Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to...

More Articles ...

  1. New football simulator Football for Friendship World to be released on World Football Day
  2. FP Markets recognised as 'Best FX Broker Australia' for 2020
  3. Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform-PR Newswire APAC
  4. Cloud4C and SNP Ink Global Partnership Agreement-PR Newswire APAC
  5. Healthscope selects Adoreboard to improve Patient Experience in a Post-COVID World-PR Newswire APAC
  6. SOR Autonomous Security Drone Collaboration
  7. Hi-Chew goes bigger and better with hit social media campaign-PR Newswire APAC
  8. The Swedish battery technology company TEXEL signs agreement with Curtin University in Australia to develop next generation battery-PR Newswire APAC
  9. Maire Tecnimont Group's NextChem And Indian Oil Corporation Sign India's First Circular Economy MoU-PR Newswire APAC
  10. The third CIIE to offer more with six business exhibition areas-PR Newswire APAC

Business News

Strategic partnerships to enable global acceleration for Aussie fashion brands: SHEIN Xcelerator launches

SHEIN Xcelerator is introducing a more agile, demand-led operating model, allowing brands to scale while retaining control over creative direction and identity. For fashion brands, the pressure t...

Daily Bulletin - avatar Daily Bulletin

Tips for Avoiding Probate Delays

Probate can be a lengthy process at the best of times, and delays often compound the stress that comes with managing a loved one's estate. Many of those delays are avoidable with the right preparati...

Daily Bulletin - avatar Daily Bulletin

Integrating Marketing Automation Workflows with Headless CMS: Creating a Unified Engine for Scalable Growth

Marketing automation is a necessary component of modern engagement with customers. Automated emails, triggered campaigns, lead nurturing and lifecycle messaging enable brands to scale their messagin...

Daily Bulletin - avatar Daily Bulletin